| #51 |
Sanjay Chanda |
Neurogesx |
1 |
| #51 |
John Affaki |
Google |
1 |
| #51 |
Peter Dragovich |
Genentech |
1 |
| #51 |
Francis Gosselin |
Genentech |
1 |
| #51 |
Leo Now |
— |
1 |
| #51 |
Ihab Darwish |
Rigel Pharmaceuticals |
1 |
| #51 |
Raymond Thomas Perry |
Analog Devices International Unlimited |
1 |
| #51 |
Benjamin M. Alba |
Amgen |
1 |
| #51 |
Hartmut Koeppen |
Genentech |
1 |
| #51 |
Stephen Senatore |
Xirgo Technologies |
1 |
| #51 |
Bernd Wranik |
Genentech |
1 |
| #51 |
Robert Grossman |
Fluidigm |
1 |
| #51 |
Lukas Grunwald |
— |
1 |
| #51 |
Bonnee Rubinfeld |
Genentech |
1 |
| #51 |
Luke Xie |
Genentech |
1 |
| #51 |
Mukund Patel |
Medtronic |
1 |
| #51 |
David Chernoff |
Adamas Pharmaceuticals |
1 |
| #51 |
Meenakshi S. Venkatraman |
Corsair Pharma |
1 |
| #51 |
Richard E. Zawitz |
Tangle |
1 |
| #51 |
John Lee |
Polaroid |
1 |
| #51 |
Yihong Li |
Abbott |
1 |
| #51 |
Albert W. Garofalo |
Elan Pharmaceuticals |
1 |
| #51 |
Adam David ROSENTHAL |
MIT |
1 |
| #51 |
Jeremy M. Murray |
Genentech |
1 |
| #51 |
Akbar Thobhani |
Ox Labs |
1 |
| #51 |
Jack Liang |
Codexis |
1 |
| #51 |
Jason A. Duquette |
Amgen |
1 |
| #51 |
David L. Wertheimer |
Google |
1 |
| #51 |
Ngiap-Kie Lim |
Genentech |
1 |
| #51 |
Jian-Xin Duan |
Threshold Pharmaceuticals |
1 |
| #51 |
Yingnan Zhang |
Genentech |
1 |
| #51 |
Wenhao Li |
Millennium Pharmaceuticals |
1 |
| #51 |
Jeff Gardina |
Cytokinetics |
1 |
| #51 |
Lauri Diehl |
Genentech |
1 |
| #51 |
Sui Yuan Lawn Lee |
— |
1 |
| #51 |
Hong-Bing Shu |
National Jewish Health |
1 |
| #51 |
Keena Lynn Green |
Roche Palo Alto |
1 |
| #51 |
Lewis Gazzard |
Genentech |
1 |
| #51 |
Jung-Sook Lee |
Samsung |
1 |
| #51 |
Philippe Bergeron |
Genentech |
1 |
| #51 |
James P. Davidson |
Ardelyx |
1 |
| #51 |
Paul A. Barsanti |
Novartis Ag |
1 |
| #51 |
Alex Chun Lap Yeung |
Apple |
1 |
| #51 |
Keelung Hong |
Taiwan Liposome Co. |
1 |
| #51 |
Wenlu Li |
Diadexus |
1 |
| #51 |
Paul Nagel |
Kinestral Technologies |
1 |
| #51 |
Robert Cafferkey |
Diadexus |
1 |
| #51 |
Boris Wolf |
— |
1 |
| #51 |
Dennis Lunev |
Swsoft Holdings |
1 |
| #51 |
Roel Funke |
Exelixis |
1 |